Nutritional Formulation for Angelman Syndrome

Summary

Nutritional Formulation for Angelman Syndrome is a clinical trial^[1].

Key Facts

• Nutritional Formulation for Angelman Syndrome is in the country of United States^[2].
• Nutritional Formulation for Angelman Syndrome's instance of is recorded as clinical trial^[3].
• Nutritional Formulation for Angelman Syndrome's start time is recorded as +2018-08-13T00:00:00Z^[4].
• Nutritional Formulation for Angelman Syndrome's end time is recorded as +2019-06-30T00:00:00Z^[5].
• Nutritional Formulation for Angelman Syndrome's sponsor is recorded as Vanderbilt University Medical Center^[6].
• Nutritional Formulation for Angelman Syndrome's main subject is recorded as Angelman syndrome^[7].
• Nutritional Formulation for Angelman Syndrome's main subject is recorded as child^[8].
• Nutritional Formulation for Angelman Syndrome's main subject is recorded as syndrome^[9].
• Nutritional Formulation for Angelman Syndrome's number of participants is recorded as {'unit': '1', 'amount': '+15'}^[10].
• Nutritional Formulation for Angelman Syndrome's title is recorded as Evaluation of the Safety and Tolerability of a Nutritional Formulation in Angelman Syndrome^[11].
• Nutritional Formulation for Angelman Syndrome's short name is recorded as FANS^[12].
• Nutritional Formulation for Angelman Syndrome's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+4'}^[13].
• Nutritional Formulation for Angelman Syndrome's ClinicalTrials.gov ID is recorded as NCT03644693^[14].
• Nutritional Formulation for Angelman Syndrome's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+11'}^[15].
• Nutritional Formulation for Angelman Syndrome's research site is recorded as Vanderbilt University Medical Center^[16].
• Nutritional Formulation for Angelman Syndrome's research subject recruitment status is recorded as recruiting^[17].
• Nutritional Formulation for Angelman Syndrome's study type is recorded as interventional study^[18].